Jump to Main Content
An NAD+ Phosphorylase Toxin Triggers Mycobacterium tuberculosis Cell Death
- Freire, Diana Mendes, Gutierrez, Claude, Garza-Garcia, Acely, Grabowska, Anna D., Sala, Ambre J., Ariyachaokun, Kanchiyaphat, Panikova, Terezie, Beckham, Katherine S.H., Colom, André, Pogenberg, Vivian, Cianci, Michele, Tuukkanen, Anne, Boudehen, Yves-Marie, Peixoto, Antonio, Botella, Laure, Svergun, Dmitri I., Schnappinger, Dirk, Schneider, Thomas R., Genevaux, Pierre, de Carvalho, Luiz Pedro Sorio, Wilmanns, Matthias, Parret, Annabel H.A., Neyrolles, Olivier
- Molecular cell 2019
- Mycobacterium tuberculosis, animal pathogens, antitoxins, bacteria, catalytic activity, cell death, crystal structure, exotoxins, macrophages, mice, phosphates, phosphorylase, therapeutics, tuberculosis
- Toxin-antitoxin (TA) systems regulate fundamental cellular processes in bacteria and represent potential therapeutic targets. We report a new RES-Xre TA system in multiple human pathogens, including Mycobacterium tuberculosis. The toxin, MbcT, is bactericidal unless neutralized by its antitoxin MbcA. To investigate the mechanism, we solved the 1.8 Å-resolution crystal structure of the MbcTA complex. We found that MbcT resembles secreted NAD+-dependent bacterial exotoxins, such as diphtheria toxin. Indeed, MbcT catalyzes NAD+ degradation in vitro and in vivo. Unexpectedly, the reaction is stimulated by inorganic phosphate, and our data reveal that MbcT is a NAD+ phosphorylase. In the absence of MbcA, MbcT triggers rapid M. tuberculosis cell death, which reduces mycobacterial survival in macrophages and prolongs the survival of infected mice. Our study expands the molecular activities employed by bacterial TA modules and uncovers a new class of enzymes that could be exploited to treat tuberculosis and other infectious diseases.